Abstract
A robust bioinformatics capability is widely acknowledged as central to realizing the promises of toxicogenomics. Successful application of toxicogenomic approaches, such as DNA microarrays, inextricably relies on appropriate data management, the ability to extract knowledge from massive amounts of data and the availability of functional information for data interpretation. At the FDA’s National Center for Toxicological Research (NCTR), we are developing a public microarray data management and analysis software, called ArrayTrack that is also used in the routine review of genomic data submitted to the FDA. ArrayTrack stores a full range of information related to DNA microarrays and clinical and nonclinical studies as well as the digested data derived from proteomics and metabonomics experiments. In addition, ArrayTrack provides a rich collection of functional information about genes, proteins, and pathways drawn from various public biological databases for facilitating data interpretation. Many data analysis and visualization tools are available with ArrayTrack for individual platform data analysis, multiple omics data integration and integrated analysis of omics data with study data. Importantly, gene expression data, functional information, and analysis methods are fully integrated so that the data analysis and interpretation process is simplified and enhanced. Using ArrayTrack, users can select an analysis method from the ArrayTrack tool box, apply the method to selected microarray data and the analysis results can be directly linked to individual gene, pathway, and Gene Ontology analysis. ArrayTrack is publicly available online (http://www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/index.htm), and the prospective user can also request a local installation version by contacting the authors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CDISC:
-
Clinical Data Interchange Standard Consortium
- DEG:
-
Differentially Expressed Gene
- FDA:
-
Food and Drug Administration
- GO:
-
Gene Ontology
- GOFFA:
-
Gene Ontology For Functional Analysis
- HCA:
-
Hierarchical Cluster Analysis
- IPA:
-
Ingenuity Pathway Analysis
- KEGG:
-
Kyoto Encyclopedia of Genes and Genomes
- MAQC:
-
MicroArray Quality Control
- MIAME:
-
Minimum Information About a Microarray Experiment
- NCTR:
-
National Center for Toxicological Research
- PCA:
-
Principal Component Analysis
- PGx:
-
Pharmacogenomics
- SDTM:
-
Study Data Tabulation Model
- TGx:
-
Toxicogenomics
- VGDS:
-
Voluntary Genomic Data Submission
References
Schmidt CW (2002) Toxicogenomics: an emerging discipline. Environ Health Perspect 110:A750–A755
Afshari CA, Nuwaysir EF, Barrett JC (1999) Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res 59:4759–4760
Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA (1999) Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog 24:153–159
Hamadeh HK, Amin RP, Paules RS, Afshari CA (2002) An overview of toxicogenomics. Curr Issues Mol Biol 4:45–56
Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, Shi L, Casciano D (2003) ArrayTrack—supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 111:1819–1826
Frueh FW (2006) Impact of microarray data quality on genomic data submissions to the FDA. Nat Biotechnol 24:1105–1107
Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhong S, Zong Y, Slikker W Jr (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161
Guidance for Industry: Pharmacogenomic data submissions–Companion Guidance: Department of Health and Human Services (HHS), Food and Drug Administration (FDA) (August 2007) http://www.fda.gov/cder/guidance/7735dft.pdf
Clinical Data Interchange Standard Consortium (CDISC): CDISC Inc., 15907 Two Rivers Cove, Austin, Texas 78717 (2007) http://www.cdisc.org/index.html
Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, Casciano D (2004) Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 549:241–253
Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M (2001) Minimum Information About a Microarray Experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365–371
Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32(Suppl):496–501
Fielden MR, Halgren RG, Dere E, Zacharewski TR (2002) GP3: GenePix post-processing program for automated analysis of raw microarray data. Bioinformatics 18:771–773
Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116–5121
Chen T, Guo L, Zhang L, Shi LM, Fang H, Sun YM, Fuscoe JC, Mei N (2006) Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics 7(Suppl 2):S20
Sun H, Fang H, Chen T, Perkins R, Tong W (2006) GOFFA: Gene Ontology for Functional Analysis—a FDA Gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics 7(Suppl 2):S23
Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP (2002) Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 101:500–502
Shav-Tal Y, Zipori D (2002) The role of activin a in regulation of hemopoiesis. Stem Cells 20:493–500
Fang H, Perkins R, Tong W (2007) Omics integrating systems using ArrayTrack and other bioinformatics tools. Am Drug Discov 2:49–52
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Fang, H. et al. (2017). ArrayTrack: An FDA and Public Genomic Tool. In: Tatarinova, T., Nikolsky, Y. (eds) Biological Networks and Pathway Analysis. Methods in Molecular Biology, vol 1613. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7027-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7027-8_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7025-4
Online ISBN: 978-1-4939-7027-8
eBook Packages: Springer Protocols